Evaluation of a Multi-country Medical Oxygen Program
Launched by MURDOCH CHILDRENS RESEARCH INSTITUTE · Oct 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The REAL-MOXY trial is studying how medical oxygen and a device called pulse oximetry (which measures the oxygen level in the blood) are used in hospitals for children under 15 years old. This research is taking place in six countries: Nigeria, Uganda, Liberia, Rwanda, Cambodia, and Lao PDR. The goal is to find out how well these oxygen systems are working in different health facilities, identify any problems that need to be addressed, and see how practices vary based on the type of illness, such as pneumonia or neonatal conditions.
If you have a child who is under 15 and being treated for a serious illness or condition, they may be eligible to participate in this trial. Throughout the study, participants can expect to help researchers understand how care is provided in the first few hours of treatment and how oxygen therapy is delivered. The trial will also involve interviews and discussions to gather insights from both patients and healthcare workers about their experiences with oxygen therapy. This information will be crucial for improving oxygen care in hospitals, ultimately benefiting children who need it most.
Gender
ALL
Eligibility criteria
- Sub-study 1:
- • Research Question: What are the baseline pulse oximetry and oxygen practices for children admitted to participating health facilities, and what is the level of institutional readiness for oxygen service delivery? Which facilities, representative of high- and low-performing facilities and different levels of care and facility types, can be selected for additional investigation to understand current functioning of oxygen systems?
- • Setting and Population: The broader MOXY program baseline cross-sectional assessments involve 9 countries. We have selected 6 MOXY countries for the mixed methods studies outlined in this protocol - Nigeria, Uganda, Liberia, Rwanda, Cambodia and Lao PDR - based on pre-existing research collaborations, and with the aim of representing broadly different geographical contexts.
- • Baseline assessments are being conducted in all facilities participating in the MOXY program in each of the 6 study countries. From this data set, we will analyse primary and secondary outcomes for wards caring for children \<15 years (including neonatal wards where relevant).
- • Analysis/outcomes: Primary - proportion of admitted children (\<15 years, including neonates) screened with pulse oximetry. Secondary - proportion of admitted children with hypoxaemia (\<15 years, including neonates) treated with oxygen. For Real-Moxy the secondary outcome will inform identification of facilities for inclusion.
- Sub-study 2:
- • Research question: Where and how are patients managed from arrival to admission and discharge (or transfer), and how does oxygen equipment move within and between clinical areas? How do process maps vary for different clinical scenarios representing different patient groups: i) pneumonia with and without hypoxaemia; ii) severe, acute illness syndrome with WHO emergency signs (e.g., shock, multi-trauma, seizures); iii) surgical condition and iv) neonatal illness (inborn and outborn)?
- • Setting and Population: This will be conducted in 10 health facilities in each of the 6 countries (Nigeria, Uganda, Liberia, Rwanda, Lao PDR, Cambodia), selected to represent high and low functioning facility oxygen systems and include secondary and tertiary health facilities from government and non-governmental sectors (identified in sub-study 1). We will focus on admitted children (\<15 years, including neonates) with (i) pneumonia, (ii) other acute illness with WHO emergency signs, (iii) surgical conditions, and (iv) neonatal illness. We have chosen these conditions to represent diagnoses with a high prevalence of hypoxaemia, and to capture the nuances of how pulse oximetry and oxygen practices are adapted (or not adapted) to clinical scenarios (e.g., having a lower threshold to provide oxygen to a patient in shock; or targeting safe oxygen saturations in neonates).
- • Analysis/outcomes: Facility maps of patient and equipment flow.
- Sub-study 3:
- • Research question: What is the sequence of emergency care for an unwell child in the first 4 hours, and how are decisions made - particularly relating to oxygen (when to start, stop, how much, what delivery modality, etc.)? What are the points of delays to appropriate care (including pulse oximetry and oxygen) and at what points in time and location could pulse oximetry and oxygen be used better for emergency care of children?
- • Setting and Population: facilities are same as sub-study 2). Children (\<15 years, including neonates) presenting with each of 4 acute illness syndromes: (i) pneumonia, (ii) other acute illness with WHO emergency signs, (iii) surgical conditions, and (iv) neonatal illness.
- • Analysis/outcomes: Patient journey maps.
- Sub-study 4:
- • Research question: How do healthcare workers use pulse oximetry and oxygen for admitted patients, and how does this change over time and vary between patient groups, facility type, and location? How do practices compare with treatment guidelines and where are the priority areas for improving oxygen care?
- • Population and setting: Facilities are same as sub-studies 2\&3.
- • Analysis/outcomes: Narrative descriptions of handover, ward rounds, and nursing rounds, with specific emphasis on how pulse oximetry is used, and decision making for oxygen therapy.
- • Sub-study 5: Indepth interviews and focus group discussions Research questions: 5a) How do patients/caregivers perceive pulse oximetry and oxygen therapy within their broader care experience? 5b) How do healthcare workers, managers and technicians perceive oxygen therapy and the provision of oxygen-related care within the broader care provision experience?
- Population:
- • Patients and caregivers enrolled in sub-study 3 (patient journey mapping).
- • Healthcare workers (bedside), managers (including clinical and non-clinical managers) and technicians in each health facility. We will select staff with direct responsibility for wards caring for children \<15 years.
- • Analysis/outcomes: Reflexive thematic analysis of interviews and focus group discussions.
About Murdoch Childrens Research Institute
Murdoch Children's Research Institute (MCRI) is a leading pediatric research organization based in Australia, dedicated to improving child health through innovative research and clinical trials. With a focus on understanding and addressing the unique health challenges faced by children, MCRI collaborates with hospitals, universities, and community partners to translate research findings into practical solutions. The institute's multidisciplinary team of scientists, clinicians, and researchers is committed to advancing pediatric medicine and enhancing the quality of life for children and their families through groundbreaking studies and evidence-based interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Phnom Penh, , Cambodia
Vientiane, , Lao People's Democratic Republic
Monrovia, , Liberia
Ibadan, , Nigeria
Kigali, , Rwanda
Kampala, , Uganda
Patients applied
Trial Officials
Hamish Graham, PhD
Principal Investigator
Murdoch Childrens Research Institute
Carina King, PhD
Principal Investigator
Karolinska Institutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported